UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Aluminium-related osteodystrophy and desferrioxamine treatment : role of phosphorus

Nephrology, dialysis, transplantation, 1994, Vol.9 (6), p.668-674

1994

Volltextzugriff (PDF)

Effect of SCH 37224 on anti-IgE-induced formation of sulfidopeptide leukotrienes in human lung parenchyma

European journal of pharmacology, 1992-08, Vol.219 (1), p.159-164

1992

Volltextzugriff (PDF)

Interference of the new antiinflammatory compound flunoxaprofen with eicosanoid formation in various biological systems

Arzneimittel-Forschung, 1987-01, Vol.37 (1), p.27

1987

Volltextzugriff (PDF)

Prostaglandins and gastric mucosal protection by escaprazole in rats

European journal of pharmacology, 1990, Vol.187 (1-2), p.19-25

1990

Volltextzugriff (PDF)

Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)

Annals of oncology, 2006-06, Vol.17 (6), p.935-944

2006

Volltextzugriff (PDF)

Dual Targeting of HER2-Positive Cancer with Trastuzumab Emtansine and Pertuzumab: Critical Role for Neuregulin Blockade in Antitumor Response to Combination Therapy

Clinical cancer research, 2014-01, Vol.20 (2), p.456-468

2014

Volltextzugriff (PDF)

CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials

Annals of oncology, 2007-04, Vol.18 (4), p.701-708

2007

Volltextzugriff (PDF)

Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer

Annals of oncology, 2011-10, Vol.22 (10), p.2216-2226

2011

Volltextzugriff (PDF)

Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX

Annals of oncology, 2011-09, Vol.22 (9), p.1981-1987

2011

Volltextzugriff (PDF)

Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience

Annals of oncology, 2004-06, Vol.15 (6), p.875-884

2004

Volltextzugriff (PDF)

Retreatment with trastuzumab-based therapy after disease progression following lapatinib in HER2-positive metastatic breast cancer

Annals of oncology, 2012-06, Vol.23 (6), p.1436-1441

2012

Volltextzugriff (PDF)

Burdens and Benefits of Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil and Tamoxifen for Elderly Patients With Breast Cancer: The International Breast Cancer Study Group Trial VII

Journal of clinical oncology, 2000-04, Vol.18 (7), p.1412-1422

2000

Volltextzugriff (PDF)

Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer

Annals of oncology, 2010-02, Vol.21 (2), p.245-254

2010

Volltextzugriff (PDF)

Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report

Annals of oncology, 2012-11, Vol.23 (11), p.2852-2858

2012

Volltextzugriff (PDF)

Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancer

Cancer chemotherapy and pharmacology, 2009-09, Vol.64 (4), p.673-680

2009

Volltextzugriff (PDF)

Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG

Annals of oncology, 2006-02, Vol.17 (2), p.262-269

2006

Volltextzugriff (PDF)

Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer

Annals of oncology, 2008-09, Vol.19 (9), p.1541-1546

2008

Volltextzugriff (PDF)

High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel

Annals of oncology, 2001-03, Vol.12 (3), p.353-356

2001

Volltextzugriff (PDF)

Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer

Annals of oncology, 2008-08, Vol.19 (8), p.1393-1401

2008

Volltextzugriff (PDF)

Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin's lymphomas

Annals of oncology, 2005-08, Vol.16 (8), p.1352-1358

2005

Volltextzugriff (PDF)

Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer

The Lancet (British edition), 1996-05, Vol.347 (9011), p.1279-1284

1996

Volltextzugriff (PDF)

Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?

Annals of oncology, 2008-07, Vol.19 (7), p.1231-1241

2008

Volltextzugriff (PDF)

Endocrine Responsiveness and Tailoring Adjuvant Therapy for Postmenopausal Lymph Node-Negative Breast Cancer: A Randomized Trial

JNCI : Journal of the National Cancer Institute, 2002-07, Vol.94 (14), p.1054-1065

International Breast Cancer Study Group (IBCSG)

2002

Volltextzugriff (PDF)

Innovative schedule of oral idarubicin in elderly patients with metastatic breast cancer: comprehensive results of a phase II multi-institutional study with pharmacokinetic drug monitoring

Annals of oncology, 2006-05, Vol.17 (5), p.807-812

2006

Volltextzugriff (PDF)

Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF

British journal of cancer, 2002-06, Vol.86 (11), p.1705-1714

2002

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Aktive Filter

ThemaPharmacology. Drug Treatments

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(45)

Sprache

Englisch
(45)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(45)
Medical Sciences
(45)
Humans
(42)
Life Sciences & Biomedicine
(41)
Science & Technology
(41)
Female
(39)
Antineoplastic Agents
(38)
Oncology
(35)
Aged
(27)
Middle Aged
(27)
Adult
(25)
Breast Neoplasms - Drug Therapy
(24)
Breast Neoplasms - Pathology
(20)
Chemotherapy
(20)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(17)
Tumors
(17)
Breast Cancer
(15)
Fluorouracil - Administration & Dosage
(14)
Gynecology. Andrology. Obstetrics
(14)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Aluminium-related osteodystrophy and desferrioxamine treatment : role of phosphorus

Effect of SCH 37224 on anti-IgE-induced formation of sulfidopeptide leukotrienes in human lung parenchyma

Interference of the new antiinflammatory compound flunoxaprofen with eicosanoid formation in various biological systems

Prostaglandins and gastric mucosal protection by escaprazole in rats

Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)

Dual Targeting of HER2-Positive Cancer with Trastuzumab Emtansine and Pertuzumab: Critical Role for Neuregulin Blockade in Antitumor Response to Combination Therapy

CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials

Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer

Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX

Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience

Retreatment with trastuzumab-based therapy after disease progression following lapatinib in HER2-positive metastatic breast cancer

Burdens and Benefits of Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil and Tamoxifen for Elderly Patients With Breast Cancer: The International Breast Cancer Study Group Trial VII

Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer

Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report

Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancer

Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG

Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer

High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel

Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer

Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin's lymphomas

Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer

Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?

Endocrine Responsiveness and Tailoring Adjuvant Therapy for Postmenopausal Lymph Node-Negative Breast Cancer: A Randomized Trial

Innovative schedule of oral idarubicin in elderly patients with metastatic breast cancer: comprehensive results of a phase II multi-institutional study with pharmacokinetic drug monitoring

Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF

Aktive Filter

Suchergebnisse filtern